Silence Therapeutics PLC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Silence Therapeutics announces its 2025 Annual General Meeting (AGM) to be held on June 26, 2025, featuring resolutions on director re-appointments, executive compensation, auditor ratification, and adoption of new articles of association.